SCHEMBL18688088

SCHEMBL18688088

c1ccc2c(c1)[nH]c1c2c2ccccc2c2c1c1ccccc1c1oc3ccccc3c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 2/20 0.49
▸ MAP3K9 P80192 1/20 0.49
▸ CHEK1 O14757 2/20 0.46
▸ CDK5 Q00535 5/20 0.45
▸ CDK5R1 Q15078 4/20 0.45
▸ DYRK1A Q13627 2/20 0.45
▸ GSK3A P49840 2/20 0.44
▸ GSK3B P49841 2/20 0.44
▸ MEN1 O00255 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ GABRP O00591 2/20 0.40
▸ GABRD O14764 2/20 0.40
▸ GABRA1 P14867 2/20 0.40
▸ GABRB1 P18505 2/20 0.40
▸ GABRG2 P18507 2/20 0.40
▸ GABRB3 P28472 2/20 0.40
▸ GABRA5 P31644 2/20 0.40
▸ GABRA3 P34903 2/20 0.40
▸ GABRA2 P47869 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17465511 0.94 MAP3K11 (0.51) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL16049927 0.90 MAP3K11 (0.51) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL19991873 0.89 MAP3K11 (0.56) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL18688086 0.88 MAP3K11 (0.49) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL30883881 0.85 MAP3K11 (0.59) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL17228831 0.85 MAP3K11 (0.59) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL29506369 0.85 MAP3K11 (0.59) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL16275794 0.83 MAP3K11 (0.53) MAP3K11MAP3K9CHEK1CDK5CDK5R1
SCHEMBL18687723 0.83 GABRP (0.50) MAP3K11MAP3K9CDK5CDK5R1DYRK1A
SCHEMBL18687720 0.83 GABRP (0.50) MAP3K11MAP3K9CHEK1CDK5CDK5R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840457-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2020-11-17 — — US disclosed
WO-2017052099-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-03-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10840457-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OR10J3, OCIAD1 MAP3K11 1831/4885MAP3K9 1328/4885CHEK1 3827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback